MindMaze is a global leader in brain technology with a mission to accelerate humanity’s ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, biosensing, engineering, mixed reality, and artificial intelligence, we have enhanced the recovery potential of patients with neurological diseases.
Combining our FDA cleared and CE marked digital therapeutics with best-in-class motion analytics, AI, and cloud technologies, our goal is to create the universal platform for brain health.
Expanding our impact beyond healthcare, MindMaze Labs is our enterprising R&D division tasked with bringing our ground-breaking neuroscience to everyday life. By harnessing the power of the brain, our neurotechnology will empower the next generation of human-machine interfaces.
Total Funding: N/A
Funding Stage: N/A
Business Stage: Scaling Up
Market: B2C
Company Size: 1 to 25
Founded: 2012
Feb 2022
- MindMaze Raised $105M
Oct 2021
- MindMaze, has announced its collaboration with The Royal Buckinghamshire Hospital (RBH)
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at MindMaze
JEAN-MARC WISMER
Chief Operating Officer
Pierre-Emmanuel Meyer
Senior Vice President Finance
Kevin Gallagher
Chief Financial Officer
Carlos Malet
Global S&M
Phoebe Alix
Director of Strategy
Lucie Blancpain
Director Operations & Governance
Software Engineer in the Algorithms team
Lausanne
Product Quality Engineer
Lausanne
Clinical Success Manager
London, London
Accounting Assistant
Lausanne
Area Sales Manager France/Benelux
Paris
